January 21, 2025 · Form 4 insider transaction
Gallagher Kathleen P. sold 1,295 shares of Atrium Therapeutics, Inc. at $28.59 per share, a transaction worth $37.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This sale was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.